Search Results - "Carpenter, Valerie J"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Therapy-Induced Senescence: An "Old" Friend Becomes the Enemy by Saleh, Tareq, Bloukh, Sarah, Carpenter, Valerie J, Alwohoush, Enas, Bakeer, Jomana, Darwish, Sarah, Azab, Belal, Gewirtz, David A

    Published in Cancers (29-03-2020)
    “…For the past two decades, cellular senescence has been recognized as a central component of the tumor cell response to chemotherapy and radiation…”
    Get full text
    Journal Article
  2. 2

    Clearance of therapy‐induced senescent tumor cells by the senolytic ABT‐263 via interference with BCL‐XL–BAX interaction by Saleh, Tareq, Carpenter, Valerie J., Tyutyunyk‐Massey, Liliya, Murray, Graeme, Leverson, Joel D., Souers, Andrew J., Alotaibi, Moureq R., Faber, Anthony C., Reed, Jason, Harada, Hisashi, Gewirtz, David A.

    Published in Molecular oncology (01-10-2020)
    “…Senescent tumor cells can be selectively eliminated by the BH3 mimetic, ABT‐263 (navitoclax), via senolysis. We show that ABT‐263 inhibits the interaction…”
    Get full text
    Journal Article
  3. 3

    Expression of therapy-induced senescence markers in breast cancer samples upon incomplete response to neoadjuvant chemotherapy by Saleh, Tareq, Alhesa, Ahmad, Al-Balas, Mahmoud, Abuelaish, Omar, Mansour, Ahmad, Awad, Heyam, El-Sadoni, Mohammed, Carpenter, Valerie J, Azab, Bilal

    Published in Bioscience reports (28-05-2021)
    “…Senescence is a cell stress response induced by replicative, oxidative, oncogenic, and genotoxic stresses. Tumor cells undergo senescence in response to…”
    Get full text
    Journal Article
  4. 4

    Targeting tumor cell senescence and polyploidy as potential therapeutic strategies by Saleh, Tareq, Carpenter, Valerie J., Bloukh, Sarah, Gewirtz, David A.

    Published in Seminars in cancer biology (01-06-2022)
    “…Senescence is a unique state of growth arrest that develops in response to a plethora of cellular stresses, including replicative exhaustion, oxidative injury,…”
    Get full text
    Journal Article
  5. 5

    Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions by Saleh, Tareq, Carpenter, Valerie J

    Published in Molecular pharmacology (01-12-2021)
    “…Senescence is a cell state that contributes to several homeostatic and pathologic processes. In addition to being induced in somatic cells in response to…”
    Get full text
    Journal Article
  6. 6

    Senolytics for Cancer Therapy: Is All That Glitters Really Gold? by Carpenter, Valerie J, Saleh, Tareq, Gewirtz, David A

    Published in Cancers (10-02-2021)
    “…Senolytics represent a group of mechanistically diverse drugs that can eliminate senescent cells, both in tumors and in several aging-related pathologies…”
    Get full text
    Journal Article
  7. 7

    Clearance of therapy-induced senescent tumor cells by the senolytic ABT-263 via interference with BCL-X L -BAX interaction by Saleh, Tareq, Carpenter, Valerie J, Tyutyunyk-Massey, Liliya, Murray, Graeme, Leverson, Joel D, Souers, Andrew J, Alotaibi, Moureq R, Faber, Anthony C, Reed, Jason, Harada, Hisashi, Gewirtz, David A

    Published in Molecular oncology (01-10-2020)
    “…Tumor cells undergo senescence in response to both conventional and targeted cancer therapies. The induction of senescence in response to cancer therapy can…”
    Get full text
    Journal Article
  8. 8

    Senescence and castration resistance in prostate cancer: A review of experimental evidence and clinical implications by Carpenter, Valerie J., Patel, Bhaumik B., Autorino, Riccardo, Smith, Steven C., Gewirtz, David A., Saleh, Tareq

    “…The development of Castration-Resistant Prostate Cancer (CRPC) remains a major challenge in the treatment of this disease. While Androgen Deprivation Therapy…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Abstract 902: The antiandrogen bicalutamide induces senescence in LNCaP cells and quiescence in Myc CaP cells by Carpenter, Valerie J., Saleh, Tareq, Gewirtz, David A.

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract The survival benefits in prostate cancer (PCa) conferred by androgen deprivation therapies (ADT) and antiandrogens are often blunted by the…”
    Get full text
    Journal Article